DSIP Thymosin Alpha-1 DS5 DS15 TA5 TA10 SS-31 MT1 2S10 2S50 MT-2 Melanotan 2Acetate Equitable price
TDS 30 Inquiries
12656-61-0
Pharmaceutical Grade
99%
shenzhen
sc
5mg/10mg/15mg/50mg. 10 bottles per box
2027-12-31
tr
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Cerebrolysin
Other Name:Cerebrolysin;FPE 1070
CAS No.:12656-61-0
EC Number:1592732-453-0
Categories:
Research-
Class:
Synthetic cyclic heptapeptide / non-selective melanocortin receptor agonist
Status:Research compound — NOT FDA approved. FDA issued warning letters. WADA banned substance.
Mechanism:A synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) analog of α-MSH. Melanotan II is a high-affinity non-selective agonist at MC1R, MC3R, MC4R, and MC5R. MC1R activation induces melanogenesis (skin darkening/tanning); MC4R activation affects sexual function, appetite suppression, and energy homeostasis. Carries significant safety risks including nausea, hypertension, and priapism.
EC50 (Human Mc1r Ki):1.2 nM
EC50 (Human Mc5r Ki):1.0 nM
EC50 (Human Mc3r Ki):1.1 nM
EC50 (Human Mc4r Ki):2.1 nM
Source:Wikberg JES, et al. Pharmacol Res. 2000;42(5):393–420. PubChem CID 92432.DOI
Clinical Development:
References-
ChEMBL:
CHEMBL363210
PubChem:Literature:FDA Warning Letters: Melanotan II (unapproved drug); WADA Prohibited List: Melanotan II (S2 hormone modulator)
Disclaimer:Melanotan II is NOT FDA-approved. The FDA has issued multiple warning letters to companies illegally selling Melanotan II as an unapproved new drug. It is also listed on the WADA Prohibited List as a banned substance in sport. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History30 Inquiries
Country Product Purchase Quantity Date Posted
India
High Quality cerebrolysin FPE 1070 Cerebrolysin powder 99% white powder 12656-61-0 Quanjinci
28 KG Sep 26, 2023
United States
CEREBROLYSIN
1 MT Mar 10, 2026
United Kingdom
Cerebrolysin (CBL60)
10 MG Jun 18, 2026
Brazil
Cerebrolysin
60 MG Apr 21, 2026
United States
Cerebrolysin
1 KG Mar 23, 2026
United States
Cerebrolysin
500 G Feb 9, 2026
South Africa
Cerebrolysin
1 KG Dec 29, 2025
United States
cerebrolysn
10 MG Dec 5, 2025
United States
Cerebrolysin
50 G Jul 17, 2025
Ireland
Cerebrolysin
1 Nov 4, 2024
United States
Cerebrolysin
10 G Jul 8, 2026
United States
Cerebrolysin
5 G Jun 29, 2026
Ireland
cerebrolysin
1 L Jun 26, 2026
United States
cerebrolysin
3 PCS May 13, 2026
South Africa
Cerebrolysin
1 KG Dec 29, 2025
United States
Cerebrolysin POWDER
1 G Dec 2, 2025
United Kingdom
Cerebrolysin Raw Powder
10 G Nov 3, 2025
South Korea
Cerebrolysin
1 G Jun 21, 2024
Uzbekistan
CEREBROLYSIN
1 KG Sep 22, 2023
United States
Cerebrolysin
60 MG Jun 26, 2026 Post an enquiry for this product